Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Receivables (2020 - 2025)

Bioadaptives' Receivables history spans 3 years, with the latest figure at $2859.0 for Q3 2025.

  • Quarterly results put Receivables at $2859.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $2859.0 (changed N/A YoY), and the annual figure for FY2024 was $2800.0, changed.
  • Receivables for Q3 2025 was $2859.0 at Bioadaptives, roughly flat from $2859.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2859.0 in Q2 2025 to a low of $2800.0 in Q4 2024.